Professor Stephen E Moss holds the Norman Ashton Chair of Biomedical Research at the UCL Institute of Ophthalmology, where he also founded and was until 2009 the Head of the Division of Cell Biology. He obtained his PhD from Heriot-Watt University in 1986 where he studied abnormal patterns of lysosomal enzyme glycosylation in leukaemia. From there he moved to London in 1986 to take up a post-doctoral position at the Imperial Cancer Research Fund (now CRUK) where he joined a group working on the annexin family of calcium- and phospholipid-binding proteins.
In 1990 he took up a Lectureship in the Department of Physiology at University College London, progressing to a Readership in 1995 and then to the Ashton Chair in 2000 upon his move to the Institute of Ophthalmology. Since 2000 his interest has focused on the retina, and new research programmes aimed at understanding the causes of AMD, and the development of novel AMD therapeutics. His research is funded by grants from the Wellcome Trust, the MRC, BBSRC and the British Heart Foundation. Professor Moss has served on the editorial boards of several journals, he is a member of a number of learned societies, and he recently completed a term of office as President of the European Calcium Society.